With countless polls across the country from a variety of sources, including this one from the Associated Press, reporting that roughly half of all Americans are still very much on the fence about getting the COVID-19 vaccine, the U.S. Government continues to march forward.
Today, it was announced that Pfizer (PFE) and its drugmaking partner BioNTech (BNTX) have struck up a deal with the govenment to to provide 100 million more doses of its approved vaccine to the U.S. This increases the total number of vaccines that Pfizer has committed to providing, to 200 million.
The vaccine continues to be rolled out based on priority, starting with healthcare and frontline workers, before be doled out to higher risk, eldery citizens, and so on, with potential plans to have enough vaccines ready for more citizens by March, with the help of other drugmakers.
But, while Pfizer promises the extra 100 million doses will be delivered by the end of July, one can only help but wonder if sentiment doesn’t change anytime in the next few months, and possibly into 2020… could there be a situation where we have a surplus of vaccines?
Even if that’s the case, one thing is for sure… with the all the orders already put in by governments around the world and more to come, drugmakers certianly won’t be hurting. They’ve already made their money.